We provide a test that generates objective insights into whether a patient has above-normal levels of the MAF gene. In doing so, we enable pathologists with a new tool for oncologists expanding their possibilities to treat patients effectively and efficiently with bisphosphonates while minimising the possible risk of a relapse in the future. Our dedication and drive to generate clinical results, offers a new proven perspective that will progress precision medicine today.